Corporates Emcure Pharmaceuticals receives EIR from USFDA with VAI classification for… Aman Shukla Apr 18, 2025
Corporates Emcure Pharmaceuticals receives two observations for its Kurkumbh facility from US… Aman Shukla Feb 26, 2025
Corporates Emcure Pharmaceuticals Q3 FY25 Results: Revenue up 18% YoY to Rs 1963 crore, Net… Aditya Bhagchandani Feb 6, 2025
Stock Market Emcure Pharmaceuticals stock jumps over 4% after strong Q2 results Aman Shukla Nov 8, 2024
Corporates Emcure Pharmaceuticals launches Emcutix Biopharmaceuticals to expand dermatology… Aman Shukla Oct 28, 2024
Corporates Emcure Pharmaceuticals signs licensing agreement with Gilead for manufacture and… Aman Shukla Oct 3, 2024
